Ming Wang, MD

Ming Wang, MD, PhD, is the Director of Wang Vision Cataract and LASIK Center in Nashville, TN, Clinical Associate Professor of the University of Tennessee, and International President of Shanghai Aier Eye Hospital. Dr. Wang graduated from Harvard Medical School and Massachusetts Institute of Technology (MD, magna cum laude ) in Boston, Massachusetts; holds a doctorate degree in laser spectroscopy; and completed his residency at Wills Eye Hospital in Philadelphia, Pennsylvania, and his corneal...See more

Ming Wang, MD, PhD, is the Director of Wang Vision Cataract and LASIK Center in Nashville, TN, Clinical Associate Professor of the University of Tennessee, and International President of Shanghai Aier Eye Hospital. Dr. Wang graduated from Harvard Medical School and Massachusetts Institute of Technology (MD, magna cum laude ) in Boston, Massachusetts; holds a doctorate degree in laser spectroscopy; and completed his residency at Wills Eye Hospital in Philadelphia, Pennsylvania, and his corneal and refractive surgery fellowship at Bascom Palmer Eye Institute, Miami, Florida. He is an editorial board member of Cataract and Refractive Surgery Today and Refractive Eye Care . A former panel consultant to the United States Food and Drug Administration Ophthalmic Device Panel and a founding director of Vanderbilt Laser Sight Center, Dr. Wang published a paper in the world-renowned journal, Nature. This was followed by his editing of 6 ophthalmic textbooks: Corneal Topography in the Wavefront Era (SLACK Incorporated, 2005), Irregular Astigmatism: Diagnosis and Treatment (SLACK Incorporated, 2006), Corneal Dystrophy and Degeneration: A Molecular Genetic Approach (American Academy of Ophthalmology, 2003), Keratoconus and Keratoectasia: Prevention, Diagnosis and Treatment (SLACK Incorporated, 2009), Corneal Topography in the Wavefront Era, Second Edition (SLACK Incorporated, 2010), and Atlas and Clinical Guide to Corneal Topography (SLACK Incorporated, 2013). Additionally, he has published over 120 papers and book chapters. Dr. Wang has several United States patents for his inventions of new biotechnologies to restore sight, including an amniotic membrane contact lens, an adaptive infrared retinoscopic device for detecting ocular aberrations, and a digital eye bank for virtual clinical trials. His invention of amniotic membrane contact lens has been used by over 1000 surgeons in the United States in treating ocular surface diseases to restore sight. Dr. Wang is an investigator in the Food and Drug Administration clinical trial of sclera-spacing procedure to treat age-related loss of near vision (presbyopia) and UV cross-linking for the treatment of keratoconus. He introduced the femtosecond laser to China, and performed China's first LASIK procedure using this laser in 2005. He also performed the world's first femtosecond laser-assisted artificial cornea implantation (Alphacor), and the first Intacs (Addition Technologies, Inc) procedure in the United States using a new version of Intacs for keratoconus. Dr. Wang was a recipient of the Academy of Ophthalmology Honor Award, as well as the Lifetime Achievement Award of the Association of Chinese American Physicians. As the founding president of the Tennessee Chinese Chamber of Commerce, co-founder of the Tennessee Immigrant and Minority Group, and co-owner and international president of Shanghai Aier Eye Hospitals in Shanghai, China, which is the largest private eye hospital group in China today with 71 locations, Dr. Wang founded a 501c(3) nonprofit organization called the Wang Foundation for Christian Outreach to China. Dr. Wang specializes in LASIK, laser refractive lens exchange for the treatment of presbyopia, laser refractive cataract surgery, corneal and external diseases including keratoconus, and ocular surface disease treatment using amniotic membrane contact lens. He runs a busy international referral clinic for post-LASIK and post-cataract surgery complications. He founded another 501c(3) nonprofit charity, the Wang Foundation for Sight Restoration, which has also helped patients from over 40 states in the United States and 55... See less